Skip to content

AYALA PHARMACEUTICALS, INC.

CIK 0001100397

← back to feed
Revenue (TTM)
$3.49M
−92.3% YoY FY Apr 2024
Net Income (TTM)
−$33.58M
−26.5% YoY FY Apr 2024
EPS Diluted (TTM)
−$9.69
+39.1% YoY FY Apr 2024
Gross Margin
2.6%
FY Apr 2024
Operating Margin
-1,076.4%
FY Apr 2024
Net Margin
-962.3%
FY Apr 2024
Free Cash Flow (TTM)
−$26.44M
FY Apr 2024
Cash
$4.88M
FY Apr 2024
Total Debt
$18.29M
FY Apr 2024
Shares Outstanding
42.63M sh
FY Apr 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings